VOLUME 1 , ISSUE 2 ( April-June, 2023 ) > List of Articles
Aarthi Chellappan, Prashant Vaijyanath, Gunaseelan Ramalingam, Ramesh Varadharajan, Thilagavathy Rajkamal, Rajkumar Nagarajan
Keywords : Aluminum phosphide, Cardiogenic shock, Extracorporeal membrane oxygenation, Mortality, Toxicity
Citation Information : Chellappan A, Vaijyanath P, Ramalingam G, Varadharajan R, Rajkamal T, Nagarajan R. Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock in Aluminum Phosphide Toxicity. Indian J ECMO 2023; 1 (2):52-54.
License: CC BY-NC 4.0
Published Online: 23-08-2023
Copyright Statement: Copyright © 2023; The Author(s).
Introduction: Aluminum phosphide (ALP) toxicity causes high mortality, often implicated for suicidal purposes since it has no specific antidote. Release of phosphine upon ingestion leads to refractory cardiogenic shock and multiorgan failure, which are the highest predictors of mortality. Compared with conventional treatment, extracorporeal membrane oxygenation (ECMO) plays a significant role in such unsolved problems. Materials and methods: Retrospective study of 9 cases from 2021 to 2022 with an undetermined number of tablets consumed. On examination, all patients had arrhythmias, hypotension, ejection fraction (EF 10–20%), and severe metabolic acidosis. We divided our patients into groups A and B based on the time taken for initiating ECMO. In group A (4 patients) VA-ECMO was initiated within 6 hours. Group B (5 patients) patients had a delay in arrival and the late decision worsened their condition and ECMO was initiated after 8 hours of ingestion. Conclusion: Early initiation of ECMO seems to improve survival rates in ALP toxicity.